192PDRandomized trial of lisinopril or carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving trastuzumab. (23rd October 2018) - Munster, P N; Krischer, J; Tamura, R; Bello-Matricaria, L; Fink, A; McCaskill-Stevens, W; Guglin, M